Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies

Jack T Stapleton; Jinhua Xiang; Donna Klinzman; James H Mclinden

Back

Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies

Patent

Open access

Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies

Jack T Stapleton, Jinhua Xiang, Donna Klinzman and James H Mclinden

United States Patent and Trademark Office

10/14/2014

Files and links (1)

pdf

Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 a642.62 kBDownload View

PDM V1.0, Open Access

Abstract

GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.

Details

Title: Subtitle: Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies
Creators: Jack T Stapleton (Inventor)
Jinhua Xiang (Inventor)
Donna Klinzman (Inventor)
James H Mclinden (Inventor)
Contributors: University of Iowa Research Foundation (Iowa City, IA, US) (Assignee)
The United States of America, as represented by the Secretary of the Department of Veterans Affairs (Washington, DC, US) (Assignee)
Resource Type: Patent
Publisher: United States Patent and Trademark Office; United States
Patent: US Patent 8,858,946; United States Patent and Trademark Office (United States, Alexandria) - USPTO; Published; 12/179,399; 07/24/2008
Number of pages: 62 pages
Language: English
Date published: 10/14/2014
Academic Unit: UI Research Foundation; Internal Medicine
Record Identifier: 9983761996702771

Metrics

36 File views/ downloads

20 Record Views